CXCL10 and cancer: KTC1101 acts directly on immune cells to modulate T cell populations but also stimulates cancer cells to produce inflammatory cytokines, such as chemokine ligand 5 (CCL5) and C-X-C motif chemokine ligand 10 (CXCL10), which promotes CD8+ T cell chemotaxis [165].